What is the Dipna Pharmachem Ltd share price today?

The share price of BSE:DPL-M on 01 Oct 2026 (as of 15:05:45 IST) is ₹4.25.

What is the BSE:DPL-M 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the BSE:DPL-M 52 week high low range shows a high of ₹25 and a low of ₹3.9.

What is the Dipna Pharmachem Ltd market cap?

As on 01 Oct 2026, Dipna Pharmachem Ltd market cap is ₹114621000.

What is the shareholding pattern of Dipna Pharmachem Ltd Stock?

The shareholding pattern of Dipna Pharmachem Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 9.13% Foreign Institutional Investors (FII): 0% Domestic Institutional Investors (DII): 0% Mutual Funds: 0% Retail & Others: 90.87% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Dipna Pharmachem Ltd?

The Price-to-Earnings (PE) ratio of Dipna Pharmachem Ltd is 4.3549, and the Price-to-Book (PB) ratio is 0.8933, as on 01 Oct 2026.

Dipna Pharmachem Share Price

4.00-0.01 (+5.26%)

-79.50% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

+5.26%

1 Week

+1.78%

1 Month

-6.54%

3 Month

-10.31%

6 Month

-51.22%

YTD

-76.33%

1 Year

-79.50%

5 Year

10 Year

Max

-87.50%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

3.96

3.80

3.62

High

4.18

4.54

7.20

8.22

19.92

About

Dipna Pharmachem Limited is engaged in the trading and distribution of wide range of pharmaceutical raw material which is also known as APIs (Active Pharmaceutical Ingredients), Excipient and chemical formulation Read more

Trading

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

ADANIENT-ANSE

CPPLUS-ANSE

PREMIERENE-ANSE

AEGISLOG-ANSE

REDINGTON-ANSE

HONASA-ANSE

LLOYDSENT-ANSE

CELLO-ANSE

JSLL-ANSE

SREEL-TNSE

DPL-MNSE

LTP

1W Low

1W High

Market cap (₹)

2590+12 (0.47%)

2559

2634

3,53,335Cr

3890+78.55 (2.06%)

3624.65

3947.90

47,150Cr

888.9+22.9 (2.64%)

850

894

40,334Cr

1180.25+82.8 (7.54%)

1082

1253.90

38,645Cr

335.35+8.6 (2.63%)

315

356.75

25,810Cr

456+13.95 (3.16%)

435.40

465.55

14,727Cr

60.57-0.44 (-0.72%)

59.72

62.86

9,182Cr

341.7+13.1 (3.99%)

326.05

353.95

7,800Cr

343+9.3 (2.79%)

330.20

350.05

4,225Cr

264.2+14.2 (5.68%)

248.40

271.50

607Cr

4+0.07 (1.78%)

3.80

4.18

10Cr

Dipna Pharmachem Share Price

4.00-0.01 (+5.26%)

-79.50% past 1 Year

Open a free Demat account in minutes to start investing and screening .

Dipna Pharmachem Share Price

4.00-0.01 (+5.26%)

-79.50% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years33%

3 years20%

Last year-24%

Compounded Profit Growth

10 years-

5 years75%

3 years-6%

Last year-10%

Stock Price CAGR

10 years-

5 years-

3 years-35%

1 year-79%

Return on Equity

10 years19%

5 years24%

3 years4%

Last year3%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	33%	20%	-24%
-	75%	-6%	-10%
-	-	-35%	-79%
19%	24%	4%	3%

Peer Comparison

Symbol

ADANIENT-A

CPPLUS-A

PREMIERENE-A

AEGISLOG-A

REDINGTON-A

HONASA-A

LLOYDSENT-A

CELLO-A

JSLL-A

SREEL-T

DPL-M

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
2,590	₹353335 Cr	61.58	11.02	97.19	₹9339 Cr
3,890	₹47150 Cr	98.79	12.07	43.68	₹368 Cr
888.9	₹40334 Cr	24.22	10.2	45.28	₹1510 Cr
1,180.25	₹38645 Cr	29.01	7.42	44.04	₹898 Cr
335.35	₹25810 Cr	15.17	6.22	24.36	₹1490 Cr
456	₹14727 Cr	59.17	2.77	8.99	₹200 Cr
60.57	₹9182 Cr	81.77	0.38	0.91	₹283 Cr
341.7	₹7800 Cr	24.93	3.32	17.46	₹332 Cr
343	₹4225 Cr	17.87	5.31	23.32	₹222 Cr
264.2	₹607 Cr	18.5	3.02	14.74	₹29 Cr
4	₹10 Cr	3.8	0.07	1.01	₹3 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Mar 2026	Mar 2025
₹2 Cr	₹16 Cr
₹2 Cr	₹16 Cr
₹2 Cr	₹15 Cr
₹46 L	₹1 Cr
₹23 L	₹60 L
₹22 L	₹68 L
₹18 L	₹50 L

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Total Non-Current Assets

Current Assets Loans & Advances

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018
—	—	—	—	—	—	—	—
₹24 Cr	₹24 Cr	₹12 Cr	₹4 L	₹4 L	₹4 L	₹4 L	₹4 L
₹14 Cr	₹13 Cr	₹12 Cr	₹2 Cr	₹54 L	₹51 L	₹45 L	₹42 L
₹14 Cr	₹13 Cr	₹12 Cr	₹2 Cr	₹54 L	₹51 L	₹45 L	₹42 L
₹38 Cr	₹38 Cr	₹24 Cr	₹2 Cr	₹57 L	₹55 L	₹49 L	₹46 L
₹7 Cr	₹11 Cr	₹9 Cr	₹22 L	₹30 L	₹8 L	₹0	₹0
₹1 Cr	₹2 Cr	₹2 Cr	₹6 Cr	₹3 Cr	₹3 Cr	₹0	₹0
-₹29,000	-₹25,000	-₹6,000	₹0	₹0	₹0	₹0	₹0
₹9 Cr	₹13 Cr	₹11 Cr	₹6 Cr	₹4 Cr	₹3 Cr	₹0	₹0
—	—	—	—	—	—	—	—
₹76 Cr	₹75 Cr	₹36 Cr	₹23 Cr	₹12 Cr	₹8 Cr	₹8 Cr	₹5 Cr
₹40 L	₹20 L	₹14 L	₹87 L	₹41,000	₹1 L	₹2 L	₹3 L
₹8 Cr	₹7 Cr	₹5 Cr	₹4 Cr	₹9 Cr	₹6 Cr	₹6 Cr	₹5 Cr
₹54 L	₹1 Cr	₹87 L	₹40 L	₹1 L	₹0	₹2 L	₹0
₹85 Cr	₹83 Cr	₹42 Cr	₹29 Cr	₹21 Cr	₹15 Cr	₹14 Cr	₹11 Cr
₹132 Cr	₹133 Cr	₹78 Cr	₹36 Cr	₹25 Cr	₹18 Cr	₹14 Cr	₹11 Cr
₹17 Cr	₹19 Cr	₹16 Cr	₹10 Cr	₹12 Cr	₹10 Cr	₹6 Cr	₹5 Cr
—	—	—	—	—	—	—	—
₹13 L	₹11 L	₹9 L	₹8 L	₹7 L	₹7 L	₹7 L	₹1 L
₹8 L	₹7 L	₹5 L	₹4 L	₹3 L	₹3 L	₹2 L	₹75,574
₹5 L	₹4 L	₹4 L	₹4 L	₹4 L	₹4 L	₹5 L	₹51,276
₹5 L	₹4 L	₹4 L	₹4 L	₹4 L	₹4 L	₹5 L	₹51,276
—	—	—	—	—	—	—	—
₹27 Cr	₹37 Cr	₹19 Cr	₹6 Cr	₹7 Cr	₹6 Cr	₹3 Cr	₹4 Cr
₹46 Cr	₹31 Cr	₹29 Cr	₹27 Cr	₹15 Cr	₹11 Cr	₹9 Cr	₹6 Cr
₹43 L	₹14 Cr	₹6 Cr	₹21 L	₹25 L	₹18 L	₹12 L	₹30 L
₹0	₹0	₹0	₹0	₹0	₹78,000	₹0	₹0
₹58 Cr	₹51 Cr	₹24 Cr	₹3 Cr	₹2 Cr	₹1 Cr	₹2 Cr	₹44 L
₹132 Cr	₹133 Cr	₹78 Cr	₹36 Cr	₹25 Cr	₹18 Cr	₹14 Cr	₹11 Cr
₹47 Cr	₹50 Cr	₹35 Cr	₹7 Cr	₹4 Cr	₹4 Cr	₹44 L	₹45 L
₹132 Cr	₹133 Cr	₹78 Cr	₹36 Cr	₹25 Cr	₹18 Cr	₹14 Cr	₹11 Cr
₹16	₹16	₹20	₹497	₹163	₹156	₹140	₹130
₹16	₹16	₹17	₹85	₹34	₹33	₹29	₹27

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018
₹1 Cr	₹1 Cr	₹1 Cr	₹2 Cr	₹6 L	₹6 L	₹0	₹0
₹2 Cr	₹2 Cr	₹97 L	₹61 L	₹35 L	₹39 L	₹0	₹0
-₹12 Cr	-₹9 Cr	-₹23 Cr	₹1 Cr	-₹3 Cr	-₹4 Cr	₹0	₹0
-₹9 Cr	-₹5 Cr	-₹21 Cr	₹3 Cr	-₹2 Cr	-₹3 Cr	₹0	₹0
-₹9 Cr	-₹5 Cr	-₹21 Cr	₹3 Cr	-₹2 Cr	-₹3 Cr	₹0	₹0
-₹2 L	-₹1 L	-₹1 L	-₹67,712	₹44,000	₹83,000	₹0	₹0
-₹4 Cr	₹14 Cr	₹26 Cr	-₹3 Cr	₹3 Cr	₹3 Cr	₹0	₹0
-₹13 Cr	₹8 Cr	₹5 Cr	-₹4 L	₹8 L	₹6 L	₹0	₹0
₹14 Cr	₹6 Cr	₹21 L	₹25 L	₹18 L	₹12 L	₹0	₹0
₹43 L	₹14 Cr	₹6 Cr	₹21 L	₹25 L	₹18 L	₹0	₹0

Fundamental Ratios

Consolidated

Standalone

No results found

Dipna Pharmachem Share Price

4.00-0.01 (+5.26%)

-79.50% past 1 Year

Shareholding summary

Promoters

9.13%

FII

DII

Others

90.87%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Sep 2025	Mar 2025	Sep 2024
9.13%	9.13%	9.13%	9.98%	9.98%	9.98%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
90.87%	90.87%	90.87%	90.02%	90.02%	90.02%

Bulk & block deals

Name

Hriday Aatish Shah

Neerita Sanjay Jain

Sanjay Nirmal Jain Huf

Namita Hemant Jain

Hemant Naresh Jain Huf

Kalpalabdhi Securities Private Limited

Namita Hemant Jain

Kalpalabdhi Securities Private Limited

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
14 Aug 2026	Purchase	8.55 L	₹5.70	1.50 L	Bulk	0.570577	BSE
04 Aug 2026	Sell	12.18 L	₹4.10	2.97 L	Bulk	1.129741	BSE
04 Aug 2026	Sell	11.98 L	₹4.39	2.73 L	Bulk	1.038449	BSE
27 Jul 2026	Sell	7.52 L	₹4.25	1.77 L	Bulk	0.67328	BSE
07 Jul 2026	Sell	8.66 L	₹5.55	1.56 L	Bulk	0.5934	BSE
01 Jul 2026	Sell	7.77 L	₹5.89	1.32 L	Bulk	0.502107	BSE
26 May 2026	Sell	10.40 L	₹7.22	1.44 L	Bulk	0.547753	BSE
21 Nov 2025	Sell	40.03 L	₹16.89	2.37 L	Bulk	0.985644	BSE
21 Nov 2025	Purchase	40.46 L	₹16.86	2.40 L	Bulk	0.99812	BSE
20 Nov 2025	Sell	50.25 L	₹15.51	3.24 L	Bulk	1.347462	BSE

Insider trading & SAST

Client name

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type

Dipna Pharmachem Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Dipna Pharmachem Share Price

Dipna Pharmachem Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Dipna Pharmachem Share Price

Dipna Pharmachem Share Price

Oscillators

Moving averages

Dipna Pharmachem Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Dipna Pharmachem Share Price

Corporate Actions

Company details

Dipna Pharmachem Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Dipna Pharmachem Share Price

News

Dipna Pharmachem informs about clarification sought on significant movement in price

Dipna Pharmachem informs about outcome of board meeting

Dipna Pharma. reports Profit after tax of 1.41 Crores, in the September 2025 quarter

Dipna Pharmachem informs about rescheduling of board meeting

Dipna Pharmachem informs about updates

Dipna Pharmachem informs about disclosure

Dipna Pharmachem informs about updates

Dipna Pharmachem informs about press release

Dipna Pharmachem informs about newspaper advertisement

Dipna Pharmachem informs about outcome of board meeting

Dipna Pharmachem informs about newspaper advertisement

Dipna Pharmachem submits intimation of in-principle approval for rights issue

Dipna Pharmachem informs about disclosures

Dipna Pharmachem informs about appointment of CS cum CO

Dipna Pharmachem informs about disclosure

Dipna Pharmachem informs about EGM

Dipna Pharmachem informs about disclosure

Dipna Pharmachem informs about outcome of board meeting

Dipna Pharmachem informs about disclosures

Dipna Pharmachem informs about certificate

Dipna Pharmachem Ltd Share Price Today

Dipna Pharmachem Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator